Icon
+91 94997 68112
Login Register

Xartemis XR - (325;7.5 mg: Tablet, Extended Release, Oral)

Oxycodone Hydrochloride and Acetaminophen Mallinckrodt
325;7.5 mg: Tablet, Extended Release, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
None
Less Than 5
None None
Management of acute pain severe enough to require opioid treatment and in patients for whom alternative treatment options are ineffective, not tolerated or would otherwise be inadequate
Yes
****** ** *** ***** ** **** **** ** **** ******* '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****), '*** (*** *, ****), '*** (***** **, ****) *** *** ************ *********. ** ****** **** **** ****** ****** ** *** ****. ******* *** **** ***** **** ** ** *** **** ******* *** *** ************ *********. ********** **** *** *** ********* ***** *** ***** ** ********* *** *** *****. ********** **** ****** *********.
Xartemis XR Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12
*** ****** ********* ** **** *** ********* ** **** *** ********* ** **** *** ********* ** **** *** ********* ** **** *** ********* ** **** *** ********* ** **** *** ********* ** **** *** ********* ** **** *** ********* ** **** *** ********* ** **** *** *** ********* (***** ******)
******* ******* ******* ******* ******* ******* ******* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
*** ****** ** \ ** -**- ********* ** **** *** **** ** *** **, ****
******* *** \ ********* *** **, **** ******* ********* ******** ******* *** **** *** *** ****
  1. *** **, **** : ****** (*******) ******** ************ ***** *** **** ** **** ******* '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****), '*** (*** *, ****), '*** (***** **, ****)
  2. *** **, **** : ******* ******** ************ ***** *** **** ** ******.
  3. *** *, **** : ************ **** ****** (*******) **** ************ ** ******* ** '***, '***, '***, '***, '***, '***, *** '***.
  4. *** *, **** : ************ ***** * **** ******* ****** ** ******** ***** ** **.
  5. *** **, **** : ************ ***** **** ******* *** ** *** ***** **** ** **** ******* '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****), '*** (*** *, ****), '*** (***** **, ****)
  6. *** **, **** : ************ *** *** ********* ********** ** *** ****** *** ********* *** **** ** ****** ** **** ***.
  7. *** *, **** : ************ ***** *** ******* ********* ******* ****** (*******) **** ************ ** ******* ** '***, '***, '***, '***, '***, '***, '***, '***, '***, '*** *** '***.
  8. *** *, **** : ********** *** ******* **** *** ***** *** ***** ** ********** *** *** *****.
  9. *** **, **** : ************ *** ****** (*******) ******* ******** ****** **** ************ ** ****** ** '***, '***, '***, '***, '***, '***, *** '***. ** ****** ** ** * **********.
  10. *** **, **** : ************ ***** *** ******* ********* ******* ****** (*******) **** ************ ** ******* ** '***, '***, '***, '*** *** '***.
  11. *** **, **** : ************ *** ****** (*******) ******* ******** ****** **** ************ ** ****** ** '***, '***, '***, '*** *** '***. ** ****** ** ** * **********.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.